MD Anderson, the Houston-based cancer center, has announced its going to start up an organization-wide analytics initiative, aimed at creating new types of personalized cancer treatments. The cancer center said it will use the Redwood Shores, Calif.-based Oracle to lay the foundation for this analytics initiative, which will aim to bring together clinical, genomic, financial, administrative and operational information from internal and external sources.
In addition, MD Anderson will use Oracle to support its Moon Shots Program. Moon Shots is an effort that looks to convert scientific discoveries into clinical advances that reduce cancer deaths.
MD Anderson, in its quest to continuously improve cancer care outcomes and quality of life for patients, has built a culture of innovation that consistently delivers life-changing gains for cancer patients. As we focus on the next-generation of treatments – including our Moon Shots Program – we require a powerful analytical infrastructure that can yield new insight from the unprecedented volume of data available today,” John Frenzel, M.D., CMIO at MD Anderson., said in a statement.
Get the latest information on Finance and Revenues and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.